Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Advances on Type-2 Cannabinoid (CB2) Receptor Agonists and their Therapeutic Potential
Valeria Gasperi, Tatiana Guzzo, Alessandra Topai, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 12, pp. 1420-1457
Closed Access | Times Cited: 18

Showing 18 citing articles:

Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Homodimerization of CB2 cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling
Gemma Navarro, Marc Gómez‐Autet, Paula Morales, et al.
Pharmacological Research (2024) Vol. 208, pp. 107363-107363
Open Access | Times Cited: 15
CIRCE: Web-Based Platform for the Prediction of Cannabinoid Receptor Ligands Using Explainable Machine Learning
Nicola Gambacorta, Fulvio Ciriaco, Nicola Amoroso, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 18, pp. 5916-5926
Closed Access | Times Cited: 21
Modeling the Effect of Cannabinoid Exposure During Human Neurodevelopment Using Bidimensional and Tridimensional Cultures
Enrique Estudillo, Jorge Iván Castillo-Arellano, Emilio G. Martínez, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 70-70
Open Access
Biochemical strategies for opioid-sparing pain management in the operating room
Fatemeh Hosseinzadeh, Alireza Nourazarian
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101927-101927
Closed Access
Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal
Francesco Samarelli, Giovanni Graziano, Nicola Gambacorta, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 450-450
Open Access | Times Cited: 4
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies
Andrea Chicca, Daniel Bátora, Christoph Ullmer, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2424-2438
Open Access | Times Cited: 3
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats
Dimitris Spyridakos, Niki Mastrodimou, Kiran Vemuri, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 240-240
Open Access | Times Cited: 14
The cannabinoid CB 2 receptor positive allosteric modulator EC21a exhibits complicated pharmacology in vitro
Aidong Qi, Xueqing Han, Marc Quitalig, et al.
Journal of Receptors and Signal Transduction (2024), pp. 1-9
Closed Access | Times Cited: 1
An In Silico Study for Expanding the Utility of Cannabidiol in Alzheimer’s Disease Therapeutic Development
Kyudam Choi, Yurim Lee, Cheongwon Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 16013-16013
Open Access | Times Cited: 3
Challenges bringing CB₂R medicine to bedside
Pál Pacher, Uwe Grether
Open Access Government (2023) Vol. 37, Iss. 1, pp. 22-23
Open Access | Times Cited: 2
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist forin vivostudies
Andrea Chicca, Daniel Bátora, Christoph Ullmer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Homodimerization of CB2cannabinoid receptor triggered by a bivalent ligand enhances cellular signaling
Gemma Navarro, Marc Gómez‐Autet, Paula Morales, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Homodimerization of Cb2 Cannabinoid Receptor Triggered by a Bivalent Ligand Enhances Cellular Signaling
Gemma Navarro, Marc Gómez‐Autet, Paula Morales, et al.
(2024)
Open Access
Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders
Calogera M. Simonaro, Makiko Yasuda, Edward H. Schuchman
Journal of Inherited Metabolic Disease (2024)
Open Access
Visualizing the anti-inflammatory cannabinoid Type-2 receptor
Marc Nazaré, Uwe Grether
Open Access Government (2023) Vol. 38, Iss. 1, pp. 30-31
Open Access | Times Cited: 1
Rational Design, Synthesis, and Evaluation of Fluorescent CB2 Receptor Ligands for Live-Cell Imaging: A Comprehensive Review
Pinaki Bhattacharjee, Malliga R. Iyer
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1235-1235
Open Access | Times Cited: 1
Is CB₂R a hidden treasure trove for treating inflammatory diseases?
Mauro Maccarrone, Uwe Grether
Open Access Government (2022) Vol. 36, Iss. 1, pp. 28-29
Open Access | Times Cited: 1
Page 1

Scroll to top